AU1917101A - Oncolytic combinations for the treatment of cancer - Google Patents

Oncolytic combinations for the treatment of cancer

Info

Publication number
AU1917101A
AU1917101A AU19171/01A AU1917101A AU1917101A AU 1917101 A AU1917101 A AU 1917101A AU 19171/01 A AU19171/01 A AU 19171/01A AU 1917101 A AU1917101 A AU 1917101A AU 1917101 A AU1917101 A AU 1917101A
Authority
AU
Australia
Prior art keywords
cancer
treatment
oncolytic
combinations
oncolytic combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19171/01A
Inventor
Jason Scott Sawyer
Beverly Ann Teicher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1917101A publication Critical patent/AU1917101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU19171/01A 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer Abandoned AU1917101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16490299P 1999-11-11 1999-11-11
US60164902 1999-11-11
PCT/US2000/030982 WO2001034199A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Publications (1)

Publication Number Publication Date
AU1917101A true AU1917101A (en) 2001-06-06

Family

ID=22596588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19171/01A Abandoned AU1917101A (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Country Status (2)

Country Link
AU (1) AU1917101A (en)
WO (1) WO2001034199A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001091794A2 (en) * 2000-05-30 2001-12-06 Virginia Commonwealth University Vitamin d3 analogs as radiosensitizers for the treatment of cancer
US7456219B2 (en) 2002-03-04 2008-11-25 Merck Hdac Research, Llc Polymorphs of suberoylanilide hydroxamic acid
US7851486B2 (en) 2002-10-17 2010-12-14 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
US7507531B2 (en) 2002-10-17 2009-03-24 Decode Genetics Chf. Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
GB0410103D0 (en) * 2004-05-06 2004-06-09 Biolipox Ab New method
EP2437249A4 (en) 2009-05-28 2012-10-24 Bridgestone Corp Information display system and information display method
WO2019109147A1 (en) * 2017-12-06 2019-06-13 Omara Stephen Kenneth Methods of treating cancer with leukotriene receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO727097A0 (en) * 1997-06-10 1997-07-03 Unisearch Limited Method of treatment of hepatoma and pharmaceutical compositions for use therein

Also Published As

Publication number Publication date
WO2001034199A2 (en) 2001-05-17
WO2001034199A3 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2020501A (en) Chemotherapy treatment
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU3791601A (en) Treatment of coal
EP1176964B8 (en) Uses of et743 for treating cancer
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
AU5089400A (en) Arthritis treatment
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU5547000A (en) Novel treatment
AU7363000A (en) Method for reducing the risk of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU4556800A (en) Novel treatment
AU7636800A (en) Improved ricin-like toxins for treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU2001257325A1 (en) Cancer treatment
AU1592901A (en) Oncolytic combinations for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase